Eldeco Housing & Industries Ltd
ELDEHSGEldeco Housing & Industries Ltd's earnings have outrun its stock. EPS grew +12.8% in a year against a −1.5% price move.
The sharpest disagreement: profits are rising, but only −39% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a downtrend (20 weeks in) while the P/E sits at the 73rd percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +400.0% year on year, and −39% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Eldeco Housing & Industries Ltd trades at ₹784, in a downtrend and 20 weeks into that stage. That is −3.8% against its own 200-day average. It sits at 11% of a 52-week range of ₹759 to ₹984. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a downtrend — week 20 of stage 4, confirmed. At ₹784 it trades −3.8% versus its 200-day average and sits at 11% of its 52-week range (₹759–₹984).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +1,802% while the NIFTY 500 moved +273% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-08-21) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Eldeco Housing & Industries Ltd trades at 21.2× P/E, at the pricey end of its own range (73rd percentile). Its long-run median P/E is 13.3×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 21.2× is at the pricey end of its own range (73rd percentile), against a long-run median of 13.3× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +12.8% against a −1.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +6.4%/yr price move, ~−6.8%/yr came from earnings growth and ~+13.2 pp from the multiple (expanding); over 10y, of the +19.1%/yr price move, ~+6.4%/yr came from earnings growth and ~+12.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Eldeco Housing & Industries Ltd was paying for profit growth of about 22.9% a year. Profit itself has compounded 1.8% a year over the past 10 years. Today the market pays 21.2× P/E, the 73rd percentile of its own 11-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is far above what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Eldeco Housing & Industries Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −50.0% at the trough to +117.6%, a 3-quarter improving streak, ROCE holding at 8.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +24.1% | +8.6% | +0.7% | +1.6% |
| Profit | +9.1% | −18.3% | −15.0% | +1.8% |
| EPS | +12.8% | −18.2% | −14.9% | +1.7% |
| Share price | −1.5% | +2.8% | +6.4% | +19.1% |
4-Factor Sector Score
62.1/100 — rank 2 of 26 in Realty - Construction & Contracting · 81% evidence confidence
Eldeco Housing & Industries Ltd scores 62.1 out of 100 against the 26 companies it is compared with in Realty - Construction & Contracting, ranking 2. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 27.7 + 14 + 6.9 + 13.5 = 62.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Eldeco Housing & Industries Ltd reported ₹49.0 Cr of revenue in the Jun 26 quarter, +69.0% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at 1.6% a year. The last full year, FY26, came in at ₹165 Cr. The last four reported quarters add to ₹185 Cr.
FY26 revenue came in at ₹165 Cr (+24.1% on the year), capping 10 years at 1.6% compound. The latest quarter (Jun 26) printed ₹49.0 Cr, +69.0% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +38.5% growth against the decade's 1.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +38.1% over the last 4 quarters against +25.7%/yr over the last 8 — accelerating; TTM profit +117.6% vs +4.3%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Eldeco Housing & Industries Ltd's operating margin is 36.0% in the Jun 26 quarter, +25.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 14.0% to 47.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 36.0%, +25.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 14.0%–47.0%.
Why the margin moved: operating margin went +24.3 pp year on year while gross margin went +19.6 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Eldeco Housing & Industries Ltd earned ₹15.0 Cr of net profit in the Jun 26 quarter, +400.0% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹24.0 Cr. The 10-year compound rate is 1.8%. That is 30.6% of the quarter's revenue. The same quarter a year earlier earned ₹3.0 Cr.
Jun 26 profit was ₹15.0 Cr, +400.0% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹24.0 Cr (+9.1%), and the 10-year compound rate is 1.8%.
Why profit moved: revenue contributed +69.0% and the margin +25.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +140.0% vs revenue +38.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −39% of Eldeco Housing & Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹104 Cr of operating cash against ₹24.0 Cr of profit. After ₹1.0 Cr of capital spending, ₹103 Cr was left as free cash.
FY26: operating cash of ₹104 Cr against reported profit of ₹24.0 Cr, leaving free cash of ₹103 Cr after ₹1.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −39% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −39%: the cash cycle stretched 1,871 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 1,871 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Eldeco Housing & Industries Ltd's cash conversion cycle runs 3,278 days in FY26, up from 1,407 days in FY21. Capital spending ran ₹1.0 Cr over the last 3 years. At FY26 sales of ₹165 Cr each day of that cycle holds about ₹0.5 Cr, so roughly ₹1,482 Cr sits inside the business at any moment.
FY26: debtors at 2 days, inventory at 3,346 days — roughly 110.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 3,278 days, looser than FY21's 1,407.
The full loop: cash goes out to suppliers and production on day 0; stock waits 3,346 days to sell; customers pay about 2 days after that; and suppliers themselves are paid at 70 days — netting out to the 3,278-day cycle.
In money terms: at FY26 sales of ₹165 Cr, each day of the cycle holds about ₹0.5 Cr — so the 3,278-day loop keeps roughly ₹1,482 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹1.0 Cr over the last 3 fiscal years against ₹3.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Eldeco Housing & Industries Ltd earns a ROCE of 8% in FY26. That is up from a trough of 7% in FY25. Return on invested capital clears the cost of that capital by −5.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 14.5% net margin on 0.16× asset turns.
FY26 ROCE is 8%, recovered from a FY25 trough of 7% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 14.5% net margin × 0.16× asset turns × 2.63× balance-sheet leverage ≈ 6.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 6.1% − 12.0% = a −5.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Eldeco Housing & Industries Ltd carries total debt of ₹154 Cr against shareholder equity of ₹400 Cr as of Mar 26, a debt-to-equity of 0.39. On the annual view that ratio went from 0.04 in FY22 to 0.39 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹154 Cr against shareholder equity of ₹400 Cr — a debt-to-equity of 0.39. On the annual view, debt-to-equity went from 0.04 (FY22) to 0.39 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Eldeco Housing & Industries Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved +0.0 points over the same window, to 54.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +0.3 points over 8 quarters to 0.6%; Promoters: +0.0 points over 8 quarters to 54.8%; Foreign institutions: +0.0 points over 8 quarters to 0.8%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Eldeco Housing & Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Arihant Foundations & Housing LtdARIHANT | 65.0/100Favorable setup81% evidence | BREAKING OUT | 21.1/35 Revenue 88.8% · PAT 38.8% · OPM change 1 pp 95% evidence | 19.5/25 ROCE 17.5% · OPM 27% 95% evidence | 11.3/20 P/E 14.1× · PEG — 50% evidence | 13.1/20 RS sector 10.4% · RS bench -6.8% · 1Y -17.6%7 of 10 weeks ahead 70% evidence |
| Exact sum: 21.1 + 19.5 + 11.3 + 13.1 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Eldeco Housing & Industries Ltdthis pageELDEHSG | 62.1/100Mixed-positive evidence81% evidence | ASLEEP | 27.7/35 Revenue 38.1% · PAT 100% · OPM change 25 pp 95% evidence | 14.0/25 ROCE 7.7% · OPM 36% 95% evidence | 6.9/20 P/E 21.2× · PEG — 50% evidence | 13.5/20 RS sector 28.2% · RS bench -5.6% · 1Y 2.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 27.7 + 14 + 6.9 + 13.5 = 62.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Ashiana Housing LtdASHIANA | 59.8/100Mixed-positive evidence100% evidence | ASLEEP | 29.3/35 Revenue 37% · PAT 100% · OPM change 3 pp 100% evidence | 13.5/25 ROCE 14% · OPM 7% 100% evidence | 5.6/20 P/E 29.5× · PEG 4.68 100% evidence | 11.4/20 RS sector 2.8% · RS bench 6.9% · 1Y 10.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 29.3 + 13.5 + 5.6 + 11.4 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4PVP Ventures LtdPVP | 57.9/100Mixed-positive evidence72% evidence | BREAKING OUT | 22.5/35 Revenue 100% · PAT 100% · OPM change 0 pp 71% evidence | 6.6/25 ROCE 6.4% · OPM 29% 95% evidence | 8.8/20 P/E 111× · PEG — 15% evidence | 20.0/20 RS sector 92.4% · RS bench 99.4% · 1Y 125.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 6.6 + 8.8 + 20 = 57.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Arvind SmartSpaces LtdARVSMART | 56.6/100Mixed-positive evidence82% evidence | BREAKING OUT | 20.1/35 Revenue 5.3% · PAT 48% · OPM change 28 pp 95% evidence | 16.3/25 ROCE 12.4% · OPM 49% 76% evidence | 10.1/20 P/E 14.9× · PEG — 50% evidence | 10.1/20 RS sector -2.4% · RS bench 1.4% · 1Y -3.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 16.3 + 10.1 + 10.1 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Raymond LtdRAYMOND | 56.5/100Mixed-positive evidence75% evidence | LEADER | 18.8/35 Revenue 13.5% · PAT -80% · OPM change 3 pp 95% evidence | 9.3/25 ROCE 3.1% · OPM 13% 76% evidence | 9.0/20 P/E 39.7× · PEG — 15% evidence | 19.4/20 RS sector 91.8% · RS bench 98.2% · 1Y 63.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 9.3 + 9 + 19.4 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Sunteck Realty LtdSUNTECK | 53.5/100Mixed-positive evidence93% evidence | TURNING | 26.1/35 Revenue 55.5% · PAT 31.1% · OPM change 10 pp 100% evidence | 8.3/25 ROCE 7.5% · OPM 35% 100% evidence | 13.5/20 P/E 19.8× · PEG 0.87 65% evidence | 5.6/20 RS sector -22.2% · RS bench -19.2% · 1Y -35.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 8.3 + 13.5 + 5.6 = 53.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -22.2% and the one-year return is -35.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Puravankara LtdPURVA | 53.3/100Mixed-positive evidence61% evidence | TURNING | 25.3/35 Revenue 100% · PAT 100% · OPM change 9 pp 71% evidence | 11.3/25 ROCE 11.2% · OPM 22% 76% evidence | 9.5/20 P/E 31.4× · PEG — 15% evidence | 7.2/20 RS sector -13.6% · RS bench -5.4% · 1Y -26.5%2 of 10 weeks ahead 70% evidence |
| Exact sum: 25.3 + 11.3 + 9.5 + 7.2 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9AGI Infra LtdAGIIL | 52.9/100Mixed-positive evidence93% evidence | ASLEEP | 19.2/35 Revenue 3.8% · PAT 43.1% · OPM change 9 pp 100% evidence | 19.0/25 ROCE 20.1% · OPM 42% 100% evidence | 10.7/20 P/E 33.3× · PEG 1.25 65% evidence | 4.0/20 RS sector -13.1% · RS bench -9.5% · 1Y 15.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 19 + 10.7 + 4 = 52.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Kesar India Ltd543542 | 52.3/100Mixed-positive evidence67% evidence | ASLEEP | 14.7/35 Revenue 91.9% · PAT 12.6% · OPM change -6 pp 71% evidence | 17.3/25 ROCE 23.4% · OPM 8% 76% evidence | 8.9/20 P/E 82.1× · PEG — 15% evidence | 11.4/20 RS sector 3.2% · RS bench 7.9% · 1Y 83.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 17.3 + 8.9 + 11.4 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Ajmera Realty & Infra India LtdAJMERA | 52.2/100Mixed-positive evidence82% evidence | BASING | 21.8/35 Revenue 43.3% · PAT 23.5% · OPM change -1 pp 95% evidence | 16.8/25 ROCE 14.3% · OPM 29% 76% evidence | 9.2/20 P/E 14.9× · PEG — 50% evidence | 4.4/20 RS sector -24.1% · RS bench -21.5% · 1Y -41.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 16.8 + 9.2 + 4.4 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Capacite Infraprojects LtdCAPACITE | 52.0/100Mixed-positive evidence81% evidence | ASLEEP | 15.5/35 Revenue 12.4% · PAT -5.6% · OPM change -1 pp 95% evidence | 15.3/25 ROCE 15.5% · OPM 16% 95% evidence | 14.4/20 P/E 8.8× · PEG — 50% evidence | 6.8/20 RS sector -7.6% · RS bench -20.1% · 1Y -35.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 15.5 + 15.3 + 14.4 + 6.8 = 52 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Suratwwala Business Group LtdSBGLP | 51.3/100Thin evidence · provisional56% evidence | 18.4/35 Revenue 100% · PAT 100% · OPM change 45 pp 40% evidence | 12.8/25 ROCE 12.4% · OPM 37% 71% evidence | 13.9/20 P/E 16.8× · PEG — 50% evidence | 6.2/20 RS sector -13.9% · RS bench -14.8% · 1Y -11.8%2 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 18.4 + 12.8 + 13.9 + 6.2 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Kolte Patil Developers LtdKOLTEPATIL | 49.3/100Mixed-negative evidence78% evidence | BREAKING OUT | 15.1/35 Revenue 7.8% · PAT 47.1% · OPM change 53 pp 74% evidence | 7.0/25 ROCE -0.3% · OPM 21% 100% evidence | 13.9/20 P/E 31.2× · PEG 0.74 65% evidence | 13.3/20 RS sector 1.1% · RS bench 14% · 1Y -5.9%6 of 10 weeks ahead 70% evidence |
| Exact sum: 15.1 + 7 + 13.9 + 13.3 = 49.3 · Decision use: Price leads the evidence: RS versus the benchmark is 14%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Geecee Ventures LtdGEECEE | 49.0/100Mixed-negative evidence87% evidence | BREAKING OUT | 12.1/35 Revenue -6.5% · PAT 20% · OPM change -24.9 pp 95% evidence | 9.7/25 ROCE 6.3% · OPM 28.7% 95% evidence | 9.4/20 P/E 16.7× · PEG — 50% evidence | 17.8/20 RS sector 8.9% · RS bench 13% · 1Y -5.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 9.7 + 9.4 + 17.8 = 49 · Decision use: Price leads the evidence: RS versus the benchmark is 13%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Suraj Estate Developers LtdSURAJEST | 47.9/100Mixed-negative evidence87% evidence | ASLEEP | 13.2/35 Revenue 4% · PAT 1.1% · OPM change 0 pp 95% evidence | 17.7/25 ROCE 14.5% · OPM 37% 95% evidence | 13.8/20 P/E 9.1× · PEG — 50% evidence | 3.2/20 RS sector -25.6% · RS bench -22.8% · 1Y -42%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 17.7 + 13.8 + 3.2 = 47.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 17Ganesh Housing LtdGANESHHOU | 45.5/100Mixed-negative evidence100% evidence | FADING | 4.3/35 Revenue -28.6% · PAT -54.1% · OPM change -46 pp 100% evidence | 18.2/25 ROCE 18.8% · OPM 39% 100% evidence | 12.4/20 P/E 24× · PEG 0.31 100% evidence | 10.6/20 RS sector -0.8% · RS bench 2.9% · 1Y -11.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 4.3 + 18.2 + 12.4 + 10.6 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Shriram Properties LtdSHRIRAMPPS | 44.6/100Mixed-negative evidence87% evidence | ASLEEP | 19.0/35 Revenue 37% · PAT 13.6% · OPM change -12.9 pp 95% evidence | 9.1/25 ROCE 8% · OPM -3.9% 95% evidence | 12.9/20 P/E 13.4× · PEG — 50% evidence | 3.6/20 RS sector -15.8% · RS bench -12.7% · 1Y -20.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 9.1 + 12.9 + 3.6 = 44.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Keystone Realtors LtdRUSTOMJEE | 42.3/100Mixed-negative evidence76% evidence | BASING | 17.4/35 Revenue 52.6% · PAT -26.8% · OPM change 12.7 pp 95% evidence | 10.1/25 ROCE 4.7% · OPM 17% 76% evidence | 9.0/20 P/E 37.1× · PEG — 50% evidence | 5.8/20 RS sector -11.6% · RS bench -23.4% · 1Y -44%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.4 + 10.1 + 9 + 5.8 = 42.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Omaxe LtdOMAXE | 40.7/100Mixed-negative evidence63% evidence | BREAKING OUT | 13.4/35 Revenue -8.3% · PAT 29.6% · OPM change 61.9 pp 71% evidence | 2.3/25 ROCE -110% · OPM 1.8% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.0/20 RS sector 4% · RS bench 52.4% · 1Y 42.7%6 of 10 weeks ahead 70% evidence |
| Exact sum: 13.4 + 2.3 + 10 + 15 = 40.7 · Decision use: Price leads the evidence: RS versus the benchmark is 52.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Hubtown LtdHUBTOWN | 39.3/100Mixed-negative evidence77% evidence | BASING | 13.5/35 Revenue 29.1% · PAT -12.2% · OPM change -4 pp 100% evidence | 9.4/25 ROCE 9.5% · OPM 18% 100% evidence | 9.9/20 P/E 27.4× · PEG — 15% evidence | 6.5/20 RS sector -10.6% · RS bench -20.4% · 1Y -44.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 9.4 + 9.9 + 6.5 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Valor Estate LtdDBREALTY | 37.9/100Mixed-negative evidence93% evidence | ASLEEP | 23.6/35 Revenue -49.5% · PAT 100% · OPM change 24.4 pp 100% evidence | 6.5/25 ROCE 1.6% · OPM 20.8% 100% evidence | 4.3/20 P/E 440.4× · PEG 4.19 65% evidence | 3.5/20 RS sector -20.1% · RS bench -17.3% · 1Y -43.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 6.5 + 4.3 + 3.5 = 37.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.1% and the one-year return is -43.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 23Hemisphere Properties India LtdHEMIPROP | 37.5/100Thin evidence · provisional56% evidence | BASING | 10.3/35 Revenue -4.2% · PAT -46.1% · OPM change -134.2 pp 74% evidence | 4.8/25 ROCE -1.1% · OPM — 64% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.4/20 RS sector 6.5% · RS bench -11.7% · 1Y -31.6%1 of 10 weeks ahead 70% evidence |
| Exact sum: 10.3 + 4.8 + 10 + 12.4 = 37.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Peninsula Land LtdPENINLAND | 34.0/100Adverse evidence69% evidence | TURNING | 11.5/35 Revenue -50.7% · PAT -80% · OPM change -43.7 pp 71% evidence | 6.7/25 ROCE 4.9% · OPM -19.4% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.8/20 RS sector -29% · RS bench -26.7% · 1Y -54.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11.5 + 6.7 + 10 + 5.8 = 34 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25SignatureGlobal India LtdSIGNATURE | 30.7/100Adverse evidence93% evidence | BASING | 13.0/35 Revenue -23% · PAT 100% · OPM change -11.8 pp 100% evidence | 3.5/25 ROCE 2.6% · OPM -8% 100% evidence | 7.6/20 P/E 10.1× · PEG 3.94 65% evidence | 6.6/20 RS sector -19.2% · RS bench -16.1% · 1Y -31.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13 + 3.5 + 7.6 + 6.6 = 30.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Laxmi Goldorna House LtdLGHL | 28.6/100Adverse evidence80% evidence | BASING | 8.8/35 Revenue 12.4% · PAT -80% · OPM change -6 pp 95% evidence | 10.3/25 ROCE 10.1% · OPM 12.1% 95% evidence | 8.5/20 P/E 569× · PEG — 15% evidence | 1.0/20 RS sector -31.5% · RS bench -28.8% · 1Y -46.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.8 + 10.3 + 8.5 + 1 = 28.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Eldeco Housing & Industries Ltd's share price today?
Eldeco Housing & Industries Ltd trades at ₹784, −1.5% over the past year. The company is valued at ₹770 Cr. The stock sits at 11% of its 52-week range of ₹759–₹984, −3.8% versus its 200-day average. On the tape, the price is in a downtrend, 20 weeks in. — as of 11 September 2026.
What were Eldeco Housing & Industries Ltd's latest quarterly results?
Eldeco Housing & Industries Ltd reported revenue of ₹49.0 Cr and net profit of ₹15.0 Cr for the Jun 26 quarter. Revenue rose 69.0% and profit rose 400.0% year on year. Earnings per share were ₹15.37. The operating margin was 36.0%, 25.0 pp higher than a year earlier. — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's revenue?
Eldeco Housing & Industries Ltd reported revenue of ₹49.0 Cr in the Jun 26 quarter, +69.0% year on year. For the full FY26 fiscal year, revenue was ₹165 Cr (+24.1%). Over the last 10 years revenue compounded at 1.6% a year. — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's profit?
Eldeco Housing & Industries Ltd earned ₹15.0 Cr of net profit in the Jun 26 quarter, +400.0% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹24.0 Cr. The operating margin ran 36.0% in the latest quarter. — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's market cap?
Eldeco Housing & Industries Ltd's market capitalisation is ₹770 Cr at a share price of ₹784. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's P/E ratio?
Eldeco Housing & Industries Ltd trades at a P/E of 21.2×, at the 73rd percentile of its own 11-year range, against a long-run median of 13.3×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Eldeco Housing & Industries Ltd pay a dividend?
Yes — Eldeco Housing & Industries Ltd's dividend payout was 37% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd overvalued?
On its own history, Eldeco Housing & Industries Ltd looks expensive: its P/E of 21.2× sits at the 73rd percentile of its 11-year range (long-run median 13.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd growing?
Yes — Eldeco Housing & Industries Ltd is growing: latest-quarter revenue +69.0% year on year, profit +400.0%, and the margin +25.0 pp at 36.0%. The 10-year compound rates are 1.6% (revenue) and 1.8% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Eldeco Housing & Industries Ltd performing?
Eldeco Housing & Industries Ltd is in a downtrend, 20 weeks in. Its latest quarter's revenue rose 69.0% and profit rose 400.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Eldeco Housing & Industries Ltd in?
Turning around — profit growth swung from −50.0% at the trough to +117.6%, a 3-quarter improving streak, ROCE holding at 8.0%. The read comes from the last 12 quarters of growth (revenue growth +38.1% latest, profit growth +117.6% latest, eps growth +117.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd in an uptrend?
No — the price is in a downtrend (week 20 of stage 4), trading −3.8% versus its 200-day average and at 11% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd beating the market?
Not lately — on a trailing-13-week view Eldeco Housing & Industries Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-08-21), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +1,802% against the NIFTY 500's +273% — ahead of the index over the full window. — as of 11 September 2026.
Will Eldeco Housing & Industries Ltd's share price go up?
This page publishes no price forecast for Eldeco Housing & Industries Ltd. What it measures instead: the share price is ₹784, the price is in a downtrend 20 weeks in. Its P/E of 21.2× sits at the 73rd percentile of its own 11-year range. — as of 11 September 2026.
Who owns Eldeco Housing & Industries Ltd?
Promoters hold 54.8% of Eldeco Housing & Industries Ltd, foreign institutions 0.8%, domestic institutions 0.6% and the public 43.7% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Eldeco Housing & Industries Ltd have too much debt?
It is moderate — Eldeco Housing & Industries Ltd's debt-to-equity is 0.39, and operating profit covers the interest bill 10×. FY26 borrowings were ₹154 Cr against equity of ₹400 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's capex?
Eldeco Housing & Industries Ltd spent ₹1.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Eldeco Housing & Industries Ltd's cash flow?
Eldeco Housing & Industries Ltd generated ₹104 Cr of operating cash flow in FY26 and ₹103 Cr of free cash flow after ₹1.0 Cr of capital spending. Reported profit that year was ₹24.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Eldeco Housing & Industries Ltd consumed cash while reporting profit. In FY26, operating cash was ₹104 Cr against reported profit of ₹24.0 Cr. Cash-flow resolution is annual — as of 11 September 2026.
Where is Eldeco Housing & Industries Ltd in its business cycle?
Eldeco Housing & Industries Ltd's FY26 operating margin was 19.0%, against a 13-year band of 14.0%–47.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 36.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Eldeco Housing & Industries Ltd's price assume?
At its price on 13 June 2026, Eldeco Housing & Industries Ltd was priced for profit growth of about 22.9% a year. Profit itself has compounded 1.8% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Eldeco Housing & Industries Ltd story?
The sharpest disagreement: profits are rising, but only −39% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Eldeco Housing & Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Eldeco Housing & Industries Ltd's earnings have outrun its stock. EPS grew +12.8% in a year against a −1.5% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!